D. Williamson

P.1.092 Olanzapine versus lithium in relapse prevention in bipolar disorder: A randomized double-blind controlled 12-month clinical trial

A. Marneros, M. Tohen, R. Belmaker, 2003, European Neuropsychopharmacology.

P.1.091 Olanzapine's efficacy for relapse prevention in bipolar disorder: A randomized double-blind placebo-controlled 12-month clinical trial

J. Calabrese, M. Tohen, C. Bowden, 2003, European Neuropsychopharmacology.

Study of Mental Activity and Regular Training (SMART) in at risk individuals: A randomised double blind, sham controlled, longitudinal trial

P. Sachdev, H. Brodaty, B. Baune, 2011, BMC geriatrics.